The American Cancer Society aims to reverse rising rates of advanced prostate cancer with a major change in guidance for prostate-specific antigen, or PSA.

As rates of advanced prostate cancer continue a worrisome rise, the American Cancer Society is recommending that most men ages 50 to 69 get screened every other year. Those at higher risk, including Black men and others with close-family histories of the disease, should get the prostate-specific antigen blood test annually.

Men ages 70 to 74 should discuss with healthcare providers whether the PSA test makes sense for them, based on their health and life expectancy, according to the ACS.

The new guidelines, published Thursday in CA: A Cancer Journal for Clinicians, are the latest pendulum swing in screening standards for prostate cancer, which is the second-leading cause of cancer death among men, behind lung cancer.